Cargando…

Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist

Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux and occur commonly in the Canadian population. Multiple non-prescription treatment options are available for managing these symptoms, including antacids, alginates, histamine-H2 receptor antagonists (H2RAs), and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, David, Nakhla, Nardine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184381/ https://www.ncbi.nlm.nih.gov/pubmed/28042359 http://dx.doi.org/10.18549/PharmPract.2016.04.868

Ejemplares similares

Creating Standardized Tools for the Pharmacist-Led Assessment and Pharmacologic Management of Adult Canadians Wishing to Quit Smoking: A Consensus-Based Approach
por: Butt, Kristi, et al.
Publicado: (2021)

Pharmacist Prescribing for Minor Ailments Service Development: The Experience in Ontario
por: Nakhla, Nardine, et al.
Publicado: (2021)

Prescription-Equivalent Over-the-Counter Drugs for Allergy, Heartburn, and Cholesterol Reduction
por: Curtiss, Frederic R.
Publicado: (2005)

Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease
por: Penagini, Roberto, et al.
Publicado: (2015)

An Infographic Assignment to Translate Self-Care Therapeutics into Practical Application
por: Malik, Paul, et al.
Publicado: (2020)

Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol
por: Sarnaik, Mubashira K, et al.
Publicado: (2021)

The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
por: Boardman, Helen F., et al.
Publicado: (2015)

Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers
por: Russo, Michele, et al.
Publicado: (2023)

Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors
por: Alhossan, Abdulaziz, et al.
Publicado: (2019)

Peripartum mental health and the role of the pharmacist: A scoping review
por: Urslak, Randilynne, et al.
Publicado: (2023)

Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
por: Saven, Hannah, et al.
Publicado: (2022)

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
por: Baiardi, Giammarco, et al.
Publicado: (2023)

Characteristics of Pharmacists' Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study
por: Yailian, AL, et al.
Publicado: (2022)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

Pharmacists’ knowledge, perceptions and practices regarding frailty: A cross-sectional survey across practice settings in Canada
por: Malik, Paul, et al.
Publicado: (2023)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Comment on “The Role of Medications in Causing Dry Eye”
por: Nakhla, Nardine, et al.
Publicado: (2018)

Impact of Clinical Pharmacists’ Recommendations on a Proton Pump Inhibitor Taper Protocol in an Ambulatory Care Practice
por: Bundeff, Andrew W., et al.
Publicado: (2013)

Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication
por: Leontiadis, Grigorios I, et al.
Publicado: (2018)

Liq. Magnesiæ—A Remedy for Cardialgia (Heartburn.)
Publicado: (1872)

More Than Just Heartburn: Does Famotidine Effectively Treat Patients with COVID-19?
por: Malone, Robert W.
Publicado: (2021)

Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study
por: Othman, Fatmah, et al.
Publicado: (2016)

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation
por: Sharma, Rajani, et al.
Publicado: (2017)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
por: Shimada, Furitsu, et al.
Publicado: (2021)

Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit
por: Ladjouzi, Nadia, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy
por: DiGiovanni, Ernest L., et al.
Publicado: (2016)

A hidden history of heartburn: The milk-alkali syndrome
por: Swaminathan, Krishnan
Publicado: (2011)

Heartburn in Staff of Golestan Medical University, Northeast of Iran
por: Besharat, Sima, et al.
Publicado: (2009)

Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation
por: Batista, Andrea Oliveira, et al.
Publicado: (2020)

Carcinogenic NMDA Contamination of Drugs for Heartburn, Hypertension and Diabetes
por: Ali, Meher Binte
Publicado: (2021)

Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn
por: Takahashi, Satsuki, et al.
Publicado: (2021)

TMAC Savings of 90% for Heartburn Drugs in the United States
por: Curtiss, Frederic R.
Publicado: (2006)

Instructor-Blinded Study of Pharmacy Student Learning When a Flipped Online Classroom Was Implemented during the COVID-19 Pandemic
por: Malik, Paul R. V., et al.
Publicado: (2022)

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
por: Peura, David A., et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_amnab05486om55q67j07od8eqj